Unknown

Dataset Information

0

Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling.


ABSTRACT: The interleukin-22 (IL-22) signaling pathway is well known to be involved in the progression of various cancer types but its role in bone metastatic breast cancer remains unclear. We demonstrate using human GEO profiling that bone metastatic breast cancer displays elevated interleukin-22 receptor 1 (IL-22R1) and sphingosine-1-phosphate receptor 1 (S1PR1) expression. Importantly, IL-22 stimuli promoted the expression of IL-22R1 and S1PR1 in aggressive MDA-MB-231 breast cancer cells. IL-22 treatment also increased sphingosine-1-phosphate production in mesenchymal stem cells (MSCs) and induced the sphingosine-1-phosphate (S1P)-mediated chemotactic migration of MDA-MB-231 cells. This effect was inhibited by an S1P antagonist. In addition to the S1PR1 axis, IL-22 stimulated the expression of matrix metalloproteinase-9 (MMP-9), thereby promoting breast cancer cell invasion. Moreover, IL-22 induced IL22R1 and S1PR1 expression in macrophages, myeloid cell, and MCP1 expression in MSCs to facilitate macrophage infiltration. Immunohistochemistry indicated that IL-22R1 and S1PR1 are overexpressed in invasive malignant breast cancers and that this correlates with the MMP-9 levels. Collectively, our present results indicate a potential role of IL-22 in driving the metastasis of breast cancers into the bone microenvironment through the IL22R1-S1PR1 axis.

SUBMITTER: Kim EY 

PROVIDER: S-EPMC7017200 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC3088498 | BioStudies
2013-01-01 | S-EPMC3578577 | BioStudies
2019-01-01 | S-EPMC6603153 | BioStudies
2018-01-01 | S-EPMC6945803 | BioStudies
2017-01-01 | S-EPMC5650392 | BioStudies
2018-01-01 | S-EPMC5901384 | BioStudies
2018-01-01 | S-EPMC6294905 | BioStudies
2019-01-01 | S-EPMC6773441 | BioStudies
2019-01-01 | S-EPMC6560353 | BioStudies
2018-01-01 | S-EPMC6095197 | BioStudies